<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Fishing the Spread: How to Buy Illiquid Biotech Options | PowersBioStrikes</title>
    <meta name="description" content="A retail investor's guide to understanding market makers, bid/ask spreads, IV crush, and how to find an edge in biotech options trading.">

    <!-- Canonical URL -->
    <link rel="canonical" href="https://powersbiostrikes.com/blog/what-really-happens-trading-biotech-options.html">

    <!-- Open Graph / Facebook -->
    <meta property="og:type" content="article">
    <meta property="og:url" content="https://powersbiostrikes.com/blog/what-really-happens-trading-biotech-options.html">
    <meta property="og:title" content="Fishing the Spread: How to Buy Illiquid Biotech Options">
    <meta property="og:description" content="A retail investor's guide to understanding market makers, bid/ask spreads, IV crush, and how to find an edge in biotech options trading.">
    <meta property="og:image" content="https://powersbiostrikes.com/images/og-image.png">

    <!-- Twitter / X -->
    <meta name="twitter:card" content="summary_large_image">
    <meta name="twitter:site" content="@PowersBioStrike">
    <meta name="twitter:creator" content="@PowersBioStrike">
    <meta name="twitter:title" content="Fishing the Spread: How to Buy Illiquid Biotech Options">
    <meta name="twitter:description" content="A retail investor's guide to understanding market makers, bid/ask spreads, IV crush, and how to find an edge in biotech options trading.">
    <meta name="twitter:image" content="https://powersbiostrikes.com/images/og-image.png">

    <!-- Google Analytics -->
    <script async src="https://www.googletagmanager.com/gtag/js?id=G-M2VVDZKN9C"></script>
    <script>
        window.dataLayer = window.dataLayer || [];
        function gtag(){dataLayer.push(arguments);}
        gtag('js', new Date());
        gtag('config', 'G-M2VVDZKN9C');
    </script>

    <script src="https://cdn.tailwindcss.com"></script>
    <script>
        tailwind.config = {
            theme: {
                extend: {
                    colors: {
                        'dark-bg': '#0a0a0f',
                        'dark-card': '#12121a',
                        'steel': '#2a2a3a',
                        'steel-dark': '#1a1a2a',
                        'gold': '#d4af37',
                        'gold-dark': '#b8960c',
                        'gold-light': '#f0d060',
                    }
                }
            }
        }
    </script>
    <style>
        @import url('https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700;800&display=swap');
        body { font-family: 'Inter', sans-serif; }
        .prose h2 { color: #d4af37; font-size: 1.5rem; font-weight: 700; margin-top: 2.5rem; margin-bottom: 1rem; }
        .prose h3 { color: #fff; font-size: 1.25rem; font-weight: 600; margin-top: 2rem; margin-bottom: 0.75rem; }
        .prose p { color: #9ca3af; line-height: 1.75; margin-bottom: 1.25rem; }
        .prose strong { color: #fff; }
        .prose ul, .prose ol { color: #9ca3af; margin-bottom: 1.25rem; padding-left: 1.5rem; }
        .prose li { margin-bottom: 0.5rem; }
        .prose blockquote { border-left: 3px solid #d4af37; padding-left: 1rem; margin: 1.5rem 0; font-style: italic; color: #6b7280; }
    </style>
</head>
<body class="bg-dark-bg text-white antialiased">
    <!-- Navigation -->
    <nav class="fixed top-0 left-0 right-0 z-50 bg-dark-bg/95 backdrop-blur-sm border-b border-steel-dark/50">
        <div class="max-w-4xl mx-auto px-6 py-4 flex justify-between items-center">
            <a href="../" class="flex items-center gap-3">
                <svg class="h-10 w-10" viewBox="0 0 80 100" fill="none" xmlns="http://www.w3.org/2000/svg">
                    <defs>
                        <linearGradient id="boltGradNav" x1="0%" y1="0%" x2="100%" y2="100%">
                            <stop offset="0%" style="stop-color:#D4AF37"/>
                            <stop offset="100%" style="stop-color:#8B6914"/>
                        </linearGradient>
                    </defs>
                    <path d="M45 5 L25 45 L38 45 L20 95 L55 40 L40 40 Z" fill="url(#boltGradNav)"/>
                    <circle cx="20" cy="95" r="6" fill="#D4AF37" opacity="0.9"/>
                    <circle cx="45" cy="5" r="5" fill="#8B6914" opacity="0.9"/>
                    <circle cx="55" cy="40" r="4" fill="#D4AF37" opacity="0.7"/>
                </svg>
                <span class="text-gold font-bold text-xl tracking-wider">PowersBioStrikes</span>
            </a>
            <div class="flex items-center space-x-6">
                <a href="../#active-positions" class="text-gray-400 hover:text-gold transition-colors text-sm">Live Trades</a>
                <a href="./" class="text-gray-400 hover:text-gold transition-colors text-sm">Learn</a>
                <a href="https://twitter.com/PowersBioStrike" target="_blank" class="text-gray-400 hover:text-gold transition-colors">
                    <svg class="w-5 h-5" fill="currentColor" viewBox="0 0 24 24"><path d="M18.244 2.25h3.308l-7.227 8.26 8.502 11.24H16.17l-5.214-6.817L4.99 21.75H1.68l7.73-8.835L1.254 2.25H8.08l4.713 6.231zm-1.161 17.52h1.833L7.084 4.126H5.117z"></path></svg>
                </a>
            </div>
        </div>
    </nav>

    <!-- Article Header -->
    <section class="pt-32 pb-12 bg-gradient-to-b from-dark-bg to-dark-card">
        <div class="max-w-3xl mx-auto px-6">
            <a href="./" class="inline-flex items-center text-gray-500 hover:text-gold text-sm mb-6 transition-colors">
                <svg class="w-4 h-4 mr-2" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M15 19l-7-7 7-7"></path>
                </svg>
                Back to Learn
            </a>
            <h1 class="text-3xl md:text-4xl font-bold mb-4">
                Fishing the Spread: How to Buy Illiquid Biotech Options
            </h1>
            <div class="flex items-center gap-4 text-sm text-gray-500">
                <span>January 2026</span>
                <span class="w-1 h-1 bg-gray-600 rounded-full"></span>
                <span>15 min read</span>
            </div>
        </div>
    </section>

    <!-- Article Content -->
    <article class="py-12 bg-dark-card">
        <div class="max-w-3xl mx-auto px-6 prose">
            <p class="text-lg text-gray-300 mb-8">
                If you've ever placed a limit order on an illiquid biotech option and watched it sit there all day before mysteriously filling at 3:55pm, you're not alone. After years of trading binary catalyst plays, I've pieced together how this game actually works&mdash;and where retail traders like us can find an edge.
            </p>

            <h2>Those Wide Bid/Ask Spreads Aren't Random</h2>
            <p>
                You pull up a small-cap biotech option chain and see a bid of $0.40 and an ask of $1.20. That $0.80 spread feels like highway robbery. But here's what's actually happening:
            </p>
            <p>
                Those quotes are almost entirely from market makers&mdash;firms like Citadel Securities, Susquehanna, and Wolverine. They're required to provide continuous two-sided quotes in exchange for rebates and preferred exchange access. The $1.20 ask isn't what they expect to get. It's their "I'd love to get this" price. The real price is somewhere in between, and your job is to find it.
            </p>
            <p>
                When you start bidding at $0.45 and slowly walk up to $0.50... then $0.55... eventually they fill you. You've just done price discovery. You found their actual indifference point&mdash;where their hedging math works and they're willing to trade.
            </p>

            <h2>How Market Makers Actually Make Money</h2>
            <p>
                Market makers aren't betting on whether your biotech gets approved. They're capturing the spread while staying directionally neutral. Here's the basic mechanics:
            </p>
            <p>
                When they sell you a call option, they immediately buy shares of the underlying stock&mdash;enough to offset small price movements (this is called delta hedging). If the stock drifts up or down normally, they don't care. The shares offset the option exposure.
            </p>
            <p>
                Their profit comes from that gap between where they buy and sell, repeated thousands of times daily across thousands of options. The edge per trade might be $5-15, but at scale it adds up.
            </p>
            <p>
                <strong>The problem with biotech?</strong> Binary catalysts blow up their hedging models. A PDUFA result can gap a stock 50% overnight, and no amount of delta hedging saves you from that. Their hedge was sized for a $7 stock, not a $12 stock. That's why biotech spreads are so wide&mdash;it's compensation for gamma risk they can't hedge away.
            </p>

            <h2>The Information Asymmetry (It's Not as Bad as You Think)</h2>
            <p>
                Market makers have significant advantages:
            </p>
            <ul>
                <li>They see order flow through payment for order flow arrangements before it hits public exchanges</li>
                <li>They have the full depth of book while you see maybe 5-10 levels</li>
                <li>They're watching stock, options, and dark pools simultaneously</li>
                <li>Their servers sit inside the exchange building measuring latency in microseconds</li>
            </ul>
            <p>
                <strong>But here's what matters: they're not your real opponent on the fundamental bet.</strong>
            </p>
            <p>
                Market makers aren't doing what you're doing. They're not reading Phase 3 data, analyzing FDA briefing documents, checking AdCom voting history, or estimating probability of approval for specific indications. Their models say "binary event coming, price IV to compensate for gap risk." Your model says "this specific drug, this specific indication, this regulatory history&mdash;I think approval odds are 75% and options are priced for 55%."
            </p>
            <p>
                <strong>They're pricing THAT an event happens. You're pricing WHAT happens.</strong>
            </p>
            <p>
                They optimize for risk-adjusted returns across 50,000 option series. You're a specialist who knows 30 biotech names cold. Both are real edges&mdash;just different ones.
            </p>

            <h2>You're Playing Against the House, But the House is Okay With That</h2>
            <p>
                Think of it this way: you're a small leak in a very profitable boat.
            </p>
            <p>
                Market makers segment order flow into "informed" and "uninformed." The trader buying 5 calls at the ask because he saw the ticker on social media? Uninformed. Pure profit for them. You, walking bids up patiently on a catalyst you've researched for weeks? Informed. They probably lose to you over time.
            </p>
            <p>
                But they can't distinguish with certainty in real-time, and their math still works:
            </p>
            <p>
                Say 100 retail traders interact with a biotech option in a month. If 90 are uninformed and the market maker profits $50 each, that's $4,500. If 10 are informed and the market maker loses $100 each, that's -$1,000. <strong>Net profit: $3,500.</strong>
            </p>
            <p>
                They don't need to beat you. They need to beat the average. Your winners are subsidized by less sophisticated traders paying full ask prices.
            </p>

            <h2>The Art of Fishing with Limit Orders</h2>
            <p>
                My approach to illiquid options has become essentially fishing:
            </p>
            <ul>
                <li>Start your bid well below the ask&mdash;maybe 20-30% above the displayed bid</li>
                <li>Let it sit</li>
                <li>Walk it up slowly only if you need to</li>
                <li>Be patient</li>
            </ul>
            <p>
                <strong>Why do orders often fill at end of day?</strong> Several reasons work in the market maker's favor:
            </p>
            <ul>
                <li>They're waiting to see if better bids come in</li>
                <li>Theta decay works for them by waiting</li>
                <li>By 3:30pm they know their overnight book and can decide if they want your exposure</li>
                <li>If your order is day-only, they have to act or lose the opportunity&mdash;they're calling your bluff</li>
            </ul>
            <p>
                That instant fill when you bid just under the ask? That's information. You could have gone lower. Now you know.
            </p>

            <h2>Understanding IV: When Are Options Actually Cheap?</h2>
            <p>
                Implied volatility is the market's guess at how much a stock will move, annualized. For context on what's "normal":
            </p>
            <ul>
                <li>Large caps like AAPL or MSFT typically run <strong>20-35% IV</strong></li>
                <li>Normal small caps sit around <strong>40-60%</strong></li>
                <li>Biotechs with no near-term catalyst price at <strong>50-80%</strong></li>
                <li>Add a catalyst within three months: <strong>80-150%</strong></li>
                <li>Within weeks of a binary event: <strong>150-300%+</strong></li>
                <li>The day before a PDUFA? <strong>300-500%</strong> isn't unusual</li>
            </ul>
            <p>
                But "high IV" isn't the right question. The right question is: <strong>"Is IV high enough given what I expect to happen?"</strong>
            </p>
            <p>
                If you believe a stock has 75% chance of approval and will hit $15 on that approval, you can calculate expected value. If IV is only pricing a move to $11, the options might be cheap even if the IV number looks scary.
            </p>

            <h3>The IV Crush Trap</h3>
            <p>
                This kills retail traders. Stock is at $7, IV is 150% before the PDUFA, you buy $10 calls for $1.50. Approval happens. Stock goes to $9.
            </p>
            <p>
                You think you're making money. But IV collapses from 150% to 60% overnight. Your $10 calls are now worth $0.80. <strong>You were RIGHT on direction and still lost</strong> because you overpaid for volatility.
            </p>
            <p>
                Your analysis needs to answer not just "will this approve?" but "will the move exceed what IV implies?"
            </p>

            <h2>The Bottom Line</h2>
            <p>
                You're not trying to beat market makers at their game&mdash;speed, infrastructure, and information flow. You're playing a different game entirely. They're the tollbooth. You're trying to minimize the toll while making the right directional bets.
            </p>
            <p>
                <strong>The edge for retail biotech traders comes from:</strong>
            </p>
            <ul>
                <li>Deep fundamental research on specific catalysts</li>
                <li>Patience in execution</li>
                <li>Understanding that the market maker isn't your opponent on the core thesis</li>
                <li>Recognizing that your winners are effectively subsidized by less sophisticated flow</li>
            </ul>
            <p>
                Do the work. Fish patiently. And remember&mdash;that wide bid/ask spread isn't a wall, it's a negotiation.
            </p>

            <!-- Author Box -->
            <div class="mt-16 p-6 bg-dark-bg border border-steel rounded-xl">
                <div class="flex items-center gap-4">
                    <div class="w-12 h-12 bg-gold/20 rounded-full flex items-center justify-center">
                        <span class="text-gold font-bold">JP</span>
                    </div>
                    <div>
                        <div class="font-semibold text-white">Jon Powers</div>
                        <div class="text-gray-500 text-sm">Founder, PowersBioStrikes</div>
                    </div>
                </div>
            </div>
        </div>
    </article>

    <!-- CTA Section -->
    <section class="py-16 bg-dark-bg border-t border-steel-dark">
        <div class="max-w-3xl mx-auto px-6 text-center">
            <h3 class="text-2xl font-bold mb-4">Want to See This in Action?</h3>
            <p class="text-gray-400 mb-6">
                Check out my current positions and track record.
            </p>
            <a href="../#active-positions" class="inline-block px-8 py-4 bg-gradient-to-r from-gold-dark to-gold text-dark-bg font-semibold rounded-lg hover:from-gold hover:to-gold-light transition-all uppercase tracking-wide text-sm">
                View Live Trades
            </a>
        </div>
    </section>

    <!-- Footer -->
    <footer class="py-12 bg-dark-bg border-t border-steel-dark/50">
        <div class="max-w-4xl mx-auto px-6">
            <div class="flex flex-col md:flex-row justify-between items-center gap-4">
                <div class="text-gray-500 text-sm">
                    &copy; 2025 Powers Capital Investments
                </div>
                <div class="text-gray-500 text-xs text-center md:text-right max-w-xl">
                    This content is for educational purposes only. Not financial advice. Trade at your own risk.
                </div>
            </div>
        </div>
    </footer>
</body>
</html>
